Literature DB >> 27686099

Older age is associated with more MRI-detected inflammation in hand and foot joints.

Wouter P Nieuwenhuis1, Lukas Mangnus2, Hanna W van Steenbergen2, Elize C Newsum2, Tom W J Huizinga2, Monique Reijnierse3, Annette H M van der Helm-van Mil2.   

Abstract

OBJECTIVES: Although MRI is recommended for diagnostic use in detecting joint inflammation, its value in clinical practice has not been settled. Older symptom-free persons show more MRI-detected inflammation in their hands and feet. Within arthritis patients, a similar effect could be present (a general age effect). The association of age with MRI inflammation could also be enhanced by disease (disease-dependent age effect). Because both effects could have diagnostic consequences, we evaluated the association between age-at-onset and MRI-detected inflammation in early arthritis and RA.
METHODS: Unilateral contrast-enhanced MRI of the MCP joint, wrist and MTP joints was performed in 589 newly presenting early arthritis patients, of whom 229 had RA. Bone marrow oedema, synovitis and tenosynovitis were summed, yielding the MRI inflammation score. MRI findings were associated with age and compared with those of 193 (previously reported) symptom-free controls.
RESULTS: Early arthritis and RA-patients had, respectively, 2.6 (95% CI: 2.3, 3.0, P < 0.001) and 3.7 times (95% CI: 3.2, 4.3, P < 0.001) higher MRI inflammation scores than controls (adjusted for age). At higher age of onset, early arthritis and RA patients had higher MRI inflammation scores (1.03/year, P < 0.001). A similar effect was observed in controls (1.03/year, P < 0.001). The interaction term age*group (arthritis/RA vs controls) was non-significant (P = 0.80 and P = 0.23), suggesting that the age effect was not disease dependent. At the joint level, older RA patients had more extended MRI inflammation, but the preferential locations were similar.
CONCLUSION: Older age is associated with more MRI-detected inflammation, and the effect was similar in arthritis and controls. This age effect should be considered when interpreting hand and foot MRI for diagnostic purposes.
© The Author 2016. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  aging; early arthritis; magnetic resonance imaging; rheumatoid arthritis

Mesh:

Substances:

Year:  2016        PMID: 27686099     DOI: 10.1093/rheumatology/kew335

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  5 in total

1.  Changes in clinical disease activity are weakly linked to changes in MRI inflammation on treat-to-target escalation of therapy in rheumatoid arthritis.

Authors:  Fiona M McQueen; Peter Chapman; Terina Pollock; Dena D'Souza; Arier C Lee; Nicola Dalbeth; Lisa Stamp; Karen Lindsay; Anthony Doyle
Journal:  Arthritis Res Ther       Date:  2017-10-24       Impact factor: 5.156

Review 2.  Management of inflammatory rheumatic conditions in the elderly.

Authors:  Clément Lahaye; Zuzana Tatar; Jean-Jacques Dubost; Anne Tournadre; Martin Soubrier
Journal:  Rheumatology (Oxford)       Date:  2019-05-01       Impact factor: 7.580

3.  Walking Disabilities in Association With Tenosynovitis at the Metatarsophalangeal Joints: A Longitudinal Magnetic Resonance Imaging Study in Early Arthritis.

Authors:  Yousra J Dakkak; Fenne Wouters; Xanthe M E Matthijssen; Monique Reijnierse; Annette H M van der Helm-van Mil
Journal:  Arthritis Care Res (Hoboken)       Date:  2022-01-10       Impact factor: 5.178

4.  Increased frequency of intermetatarsal and submetatarsal bursitis in early rheumatoid arthritis: a large case-controlled MRI study.

Authors:  Yousra J Dakkak; Ellis Niemantsverdriet; Annette H M van der Helm-van Mil; Monique Reijnierse
Journal:  Arthritis Res Ther       Date:  2020-11-23       Impact factor: 5.156

5.  Does the presence of magnetic resonance imaging-detected osteitis at diagnosis with rheumatoid arthritis lower the risk for achieving disease-modifying antirheumatic drug-free sustained remission: results of a longitudinal study.

Authors:  L E Burgers; D M Boeters; M Reijnierse; A H M van der Helm-van Mil
Journal:  Arthritis Res Ther       Date:  2018-04-10       Impact factor: 5.156

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.